secwatch.observer — SEC 8-K summary
======================================

Issuer:     Beyond Air, Inc. (XAIR)
CIK:        0001641631
Form:       8-K
Filed at:   2024-08-09T23:59:59+00:00
Accession:  0001493152-24-030972
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 3.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Beyond Air reports Q1 revenue $0.7M, net loss $0.27/share; receives Nasdaq bid-price deficiency notice
--------------------------------------------------------------------------------

- Revenue $0.7M, up 45% QoQ from $0.5M; net loss $12.2M ($0.27/share) vs $14.1M ($0.45) year ago.
- Cash burn $13.1M; cash $21.4M; expects net cash burn <$30M in FY2025; breakeven target Q4 FY2026.
- Nasdaq notice: bid price below $1.00 for 30 days; 180-day cure until Feb 4, 2025; may consider reverse split.
- Amir Avniel appointed CEO of NeuroNOS (autism program); resigns as CBO and Board member effective Aug 15, 2024.
- Revenue guidance >$10M for FY2025; commercial progress with LungFit PH in 55+ hospitals across 10 states.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1641631/000149315224030972/0001493152-24-030972-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1641631/000149315224030972/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-030972

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer